FDA Delays Approval of Replimune’s Melanoma Therapy Despite Promising Trial Results
For now, the FDA has denied approval today of a new melanoma treatment developed by Replimune. The company’s lead drug...
For now, the FDA has denied approval today of a new melanoma treatment developed by Replimune. The company’s lead drug...
This study investigates the determinants of injury severity among HCWs at a tertiary hospital, over a five-year period. To our...
Amid rising concerns over burnout in the health care workforce, a new randomized clinical trial evaluated whether 20 minutes of meditation...
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief:...
Photo taken at Total Health & Rehab Center of Boca Raton, featuring two smiling medical professionals in front of the...
As the healthcare community continues to seek effective solutions for the growing mental health and addiction crisis, emerging therapies are...
Complementary and Alternative Medicine Market Size The global complementary and alternative medicine market size was valued at USD 179.17 billion in...
Here is a list of the top 10 trends of our field. Check them out and see which will resonate...
BEIJING, July 14, 2025 /PRNewswire/ -- Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings...